Veterinary Medicines

Poulvac Marek CVI + HVT

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Download as PDF

Product identification

Medicine name:
Poulvac Marek CVI + HVT
Poulvac Marek CVI + HVT Concentraat en oplosmiddel voor suspensie voor injectie
Poulvac Marek CVI + HVT Suspension à diluer et solvant pour suspension injectable
Poulvac Marek CVI + HVT Konzentrat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    2.90
    log10 50% cell culture infectious dose
    /
    0.20
    millilitre(s)
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    1000.00
    plaque forming unit
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Poulvac Marek Diluent: Type II glass vial of 400 ml. plastic bag or carton box with 10 glass bottles.
  • Poulvac Marek Diluent: Type II glass vial containing 200 ml. plastic bag or carton box with 10 glass bottles.
  • Poulvac Marek Diluent: PVC plastic bags containing 200 ml
  • Poulvac Marek Diluent: PVC plastic bags containing 1000 ml
  • Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 1000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
  • Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 2000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
  • Poulvac Marek Diluent: PVC plastic bags containing 400 ml
  • Poulvac Marek CVI + HVT 800 ml bag

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain, S.L.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V232364
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0102/001
Concerned member states:
  • Belgium
  • Cyprus
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Portugal
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 20/08/2025
Download
French (PDF)
Published on: 20/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 20/08/2025
Download
French (PDF)
Published on: 20/08/2025
Download
German (PDF)
Published on: 20/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 20/08/2025
Download
French (PDF)
Published on: 20/08/2025
Download
German (PDF)
Published on: 20/08/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."